Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
A small study looks into features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction. They found metastatic... Read More
Adjuvant Chemotherapy or Adjuvant Chemoradiotherapy for Gastric Cancer?—A West Cancer Center Perspective
“If you gave everybody neoadjuvant chemotherapy, is there an added benefit for chemoradiation after surgery?” Watch researchers from West Cancer Center explain... Read More
Dental care before cancer surgery might be good idea
A new study from Japan shows patients undergoing major surgery for cancer may be able to reduce complication risks by visiting a... Read More
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Have you heard of tumor mutation burdens? Recently published in JAMA, researchers discovered gastric cancer tissue samples with a MUC16 gene mutation... Read More
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
A new study via BMJ finds long-term use of low-dose aspirin and other non-selective non-steroidal anti-inflammatory drugs (NSAIDs) was associated with a... Read More
Prognostic Indicators in Stage IV Surgically Treated Gastric Cancer Patients: A Retrospective Multi-Institutional Study
A new study in Digestive Surgery investigates the short and long-term outcomes of stage 4 gastric cancer patients who are surgically treated... Read More
Endoscopic predictive factors associated with local recurrence after gastric endoscopic submucosal dissection
Scientists via Taylor & Francis find that while rates of local recurrence after endoscopic submucosal dissection (ESD) of gastric lesions are low,... Read More
Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment
Researchers evaluate prognostic differences in esophagogastric cancer stages after patients receive neoadjuvant treatment.
Identifying stomach cancer risk
New research finds people with a potentially precancerous condition are at a higher risk of developing gastric cancer if samples from their... Read More
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
Scientists review the emerging trends in the use of antagonists to proteins PD-1/PD-L1 and gastrointestinal tumors.
